Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts

American Journal of Hematology

Volumn 54, Issue 2, 1997, Pages 131-138

  Storek, Jan ^a,b   Gooley, Ted ^a   Witherspoon, Robert P ^a   Sullivan, Keith M ^a   Storb, Rainer ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

CD4+ T cells; infectious morbidity; transplant

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CLINICAL ARTICLE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; LYMPHOCYTE COUNT; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MORBIDITY; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031042008     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y     Document Type: Article

References (60)

1. Forman SJ, Blume KG, Donnall TE: Bone Marrow Transplantation. Boston: Blackwell, 1994.
2. Atkinson K: Clinical Bone Marrow Transplantation. Cambridge: Cambridge University Press, 1994.
3. Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED: Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60:714, 1982.
4. Marks DI, Cullis JO, Ward KN, Lacey S, Syzdlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, et al: Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 119:207, 1993.
5. Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD: Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 10 (Suppl 1):127, 1992.
6. Muller-Hermelink HK, Sale GE, Borisch B, Storb R: Pathology of the thymus after allogeneic bone marrow transplantation in man. Am J Pathol 129:242, 1987.
7. Sale GE, Alavaikko M, Schaefers KM, Mahan CT: Abnormal CD4:CD8 rations and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease: An immunohistological study. Exp Hematol 20:1017, 1992.
8. El-Eid MA, Tutschka PJ, Wagner HN, Santos GW, Tsan MF: Functional asplenia in patients with chronic GVHD. J Nucl Med 24:1123, 1983.
9. Kahls P, Panzer S, Kletter K, Minar E, Stain-Kos M, Walter R, Lechner K, Hinterberger W: Functional asplenia after bone marrow transplantation: A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med 109:461, 1988.
10. Atkinson K, Hansen JA, Storb R, Goehle S, Goldstein G, Thomas ED: T cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 59:1292, 1982.
11. Friedrich W, O'Reilly RJ, Koziner B, Gebhard DF, Good RA, Evans RL: T-lymphocyte reconstitution in recipients of bone marrow trans- plants with and without GVHD: Imbalances of T cell subpopulations having unique regulatory and cognitive functions. Blood 59:696, 1982.
12. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989.
13. Bengtsson M, Totterman TH, Smedmyr B, Festin R, Oberg O, Simonsson B: Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 3:68, 1989.
14. Velardi A, Terenzi A, Cucciaioni S, Millo R, Grossi CE, Grignani F, Martelli MF: Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation. Blood 71:1196, 1988.
15. Storek J, Witherspoon RP, Storb R: T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16:413, 1995.
16. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A: B cell reconstitution after human bone marrow transplantation: Recapitulation of ontogeny? Bone Marrow Transplant 12:387, 1993.
17. Small TN, Keever CA, Weiner-Fedus S, Heller G, RJ OR, Flomenberg N: B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny. Blood 76:1647, 1990.
18. Kagan JM, Champlin RE, Saxon A: B cell dysfunction following human BMT: Functional-phenotypic dissociation in the early post-transplant period. Blood 74:777, 1989.
19. Pahwa SG, Pahwa RN, Friedrich W, O'Reilly RJ, Good RA: Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. Proc Natl Acad Sci USA 79:2663, 1982.
20. Lum LG, Seigneuret MC, Storb R, Wilherspoon RP, Thomas ED: In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T cell and B cell deficiencies in patients with and without chronic GVHD. Blood 58:431, 1981.
21. Matsue K, Lum LG, Witherspoon RP, Storb R: Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. Blood 69:308, 1987.
22. Storek J, Witherspoon RP, Luthy D, Storb R: Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells. Bone Marrow Transplant 15:679, 1995.
23. Witherspoon RP, Matthews D, Storb R, Atkinson K, Cheever M, Deeg HJ, Doney K, Kalbfleisch J, Noel D, Prentice R, Sullivan KM, Thomas ED: Recovery of in vivo cellular immunity after human marrow grafting. Transplantation 37:145, 1984.
24. Wilherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, Deeg JH, Sosa R, Noel DR, Atkinson K, Thomas ED: Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58:360, 1981.
25. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, Paulin T, Ringden O, Pepe MS, Gahrton G: Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 162:496, 1990.
26. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, Strauss N, Parag G, Naparstek E, Ravid Z, et al: Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and aulologous BMT recipients. Bone Marrow Transplant 11:1, 1993.
27. Barra A, Cordonnier C, Preziosi MP, Intrator L, Hessel L, Fritzell B, Preud'homme JL: Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 166:1021, 1992.
28. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F, Vernant JP, Preud'homme JL: Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 70:779, 1987.
29. Norhagen G, Engstrom PE, Bjorkstrand B, Hammarstrom L, Smith EIE, Ringden O: Salivary and serum immunoglobulins in recipients of transplanted atlogeneic and autologous bone marrow. Bone Marrow Transplant 14:229, 1994.
30. Gerritsen EJ, Van Tol MJ, Van't Veer MB, Wels JM, Khouw IM, Touw CR, Jol-Van Der Zijde CM, Hermans J, Rumke HC, Radl J, et al: Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood 84:4374, 1994.
31. Storek J, King L, Ferrara S, Marcelo D, Saxon A, Braun J: Abundance of a restricted fetal B cell repertoire in marrow transplant recipients. Bone Marrow Transplant 14:783, 1994.
32. Thomas ED, Storb R, Buckner CD: Total-body irradiation in preparation for marrow engraftment. Transplant Proc 8:591, 1976.
33. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382, 1987.
34. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, et al: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994.
35. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, et al: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986.
36. Deeg HJ, Loughran TP, Jr., Storb R, Kennedy MS, Sullivan KM, Doney K, Appelbaum FR, Thomas ED: Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 40:162, 1985.
37. Byers VS, Henslee PJ, Kernan NA, Blazar BR, Gingrich R, Phillips GL, LeMaistre CF, Gilliland G, Antin JH, Martin P, et al: Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease, blood 75:1426, 1990.
38. Anasetti C, Martin PJ, Storb R, Appelbaum FR, Beatty PG, Davis J, Doney K, Hill HF, Stewart P, Sullivan KM, et al: Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation 54:844, 1992.
39. Anasetti C, Hansen JA, Waldmann TA, Appelbaum FR, Davis J, Deeg HJ, Doney K, Martin PJ, Nash R, Storb R, et al: Treatment of acute graft-versus-host disease with humanized anti-Tac: An antibody that binds to the interleukin-2 receptor. Blood 84:1320, 1994.
40. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, et al: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72:555, 1988.
41. Przepiorka D, Thomas ED, Durnam DM, Fisher L: Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol 95:201, 1991.
42. Ugozzoli L, Yam P Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB: Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 77:1607, 1991.
43. Mushe DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE: Pneu- mococcal polysaccharide vaccine in young adults and older bronchitics: Determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 161:728, 1991.
44. + T-lymphocyte regeneration after intensive chemotherapy [see Comments]. N Engl J Med 332:143, 1995.
45. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW: Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol 150:1105, 1993.
46. Sheridan JF: Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic BMT. Blood 75:1583, 1990.
47. Azuma M, Phillips JH, Lanier LL: CD28-T lymphocytes: Antigenic and functional properties, J Immunol 150:1147, 1993.
48. Linsley PS, Lebetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993.
49. Lombardi G, Sidhu S, Batchelor R, Lechler R: Anergic T cells as suppressor cells in vitro. Science 264:1587, 1994.
50. + cells with a limited alloreactive T cell receptor repertoire. J Immunol 143:2783, 1989.
51. Emara MA, Mozes MF: Cytotoxic T-cell role in renal allograft rejection and regulation. Renal allograft infiltrating cytotoxic T-cell line with suppressor-inducer function. Hum Immunol 42:161, 1995.
52. + contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. J Leuk Biol 58:159, 1995.
53. Utzunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F: Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett 44:59, 1995.
54. Lum LG: Recapitulation of immune ontogeny: A vital component for the success of bone marrow transplantation. Cancer Treat Res 50:27, 1990.
55. Storek J, Saxon A: Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 9:395, 1992.
56. Parkman R: Immunological reconstitution following bone marrow transplantation. In Forman SJ, Blume KG, Thomas ED (eds): "Bone Marrow Transplantation." Boston: Blackwell, 1994, p 504.
57. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A: The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group [see Comments]. N Engl J Med 322:161, 1990.
58. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC, Stansell J, Turner J, Osmond D, Merrifield C, Mossar M, Hirschtick R, Meiselman L, Manghisi KJ, Schneider RF, Reichman LB, Mangura B, Barnes S, Richer B, Au J, Coulson A, et al: Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 333:845, 1995.
59. Stiehm ER: "Immunologic Disorders in Infants and Children." Philadelphia: Saunders. 1989.
60. Hollander H, Katz MK: HIV infection. In Tierney LM, McPhee SJ, Papadakis MA (eds): "Current Medical Diagnosis and Treatment." Norwalk, CT: Appleton & Lange, 1995, p 1103.